Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

248
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
248
Human Genetics01:28

Human Genetics

576
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
576
Proteomics01:33

Proteomics

7.3K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of the 90% effective dose of intranasal dexmedetomidine for sedation during electroencephalography in children.

Acta anaesthesiologica Scandinavica·2019
Same author

Sperm Movement Control Utilizing Surface Charged Magnetic Nanoparticles.

Journal of nanoscience and nanotechnology·2019
Same author

Thiophenol-formaldehyde triazole causes apoptosis induction in ovary cancer cells and prevents tumor growth formation in mice model.

European journal of medicinal chemistry·2019
Same author

Restless legs syndrome in end stage renal disease patients undergoing hemodialysis.

BMC neurology·2019
Same author

RETRACTED: MicroRNA-34 suppresses proliferation of human ovarian cancer cells by triggering autophagy and apoptosis and inhibits cell invasion by targeting Notch 1.

Biochimie·2019
Same author

Metabolic reprogramming of macrophages during infections and cancer.

Cancer letters·2019

Related Experiment Video

Updated: Jul 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Progress of depression mechanism based on Omics method.

Yaping Bo1, Qing Yu1, Wenyuan Gao1

  • 1School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, PR China.

Journal of Pharmaceutical and Biomedical Analysis
|January 6, 2024
PubMed
Summary
This summary is machine-generated.

This review explores proteomic and metabolomic analyses in animal models to understand depression's complex mechanisms. Combining these "omics" approaches offers new insights into depression

Keywords:
Complementary omics strategyDepression modelMetabolomicsProteomics

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.3K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

541

Related Experiment Videos

Last Updated: Jul 6, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.3K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

541

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Depression is a prevalent, disabling mental disorder with significant mortality and disability rates.
  • The precise physiopathology of depression remains incompletely understood despite ongoing research.
  • Advancements in technology offer new avenues for investigating depression's underlying mechanisms.

Purpose of the Study:

  • To review the application of combined proteomic and metabolomic approaches in depression research.
  • To analyze metabolites and proteins in animal models of depression.
  • To enhance understanding of depression's physiopathological mechanisms through a complementary "omics" strategy.

Main Methods:

  • Utilizing proteomic analysis to study protein expression patterns in depression models.
  • Employing metabolomic analysis to investigate metabolic alterations in depression models.
  • Integrating data from proteomic and metabolomic studies in various animal models of depression.

Main Results:

  • Proteomic and metabolomic analyses reveal distinct molecular signatures associated with depression.
  • Combined "omics" approaches provide a more comprehensive view of depression's biological underpinnings.
  • Identification of potential biomarkers and therapeutic targets for depression.

Conclusions:

  • The integration of proteomic and metabolomic strategies is crucial for elucidating depression's complex pathophysiology.
  • Complementary "omics" approaches in animal models advance the understanding and potential treatment of depression.
  • Future research should focus on validating findings and translating them into clinical applications.